Childhood acute myeloid leukaemia (AML) prognosis
AML is a life-threatening illness. But research and clinical trials continue to improve treatments and offer a better chance of a cure.
Your child's prognosis is personal
AML is a life-threatening illness, but the chance of long-term survival for children and young adults with AML has improved in recent years.
Children and young adults with AML can have stronger treatments than older people, and most respond well to the treatment.
Everyone is different, so your child’s consultant (specialist doctor) is the best person to tell you about their individual prognosis (what’s likely to happen in the future).
Not everyone wants information about their child’s prognosis. If you don’t want to talk about it, tell your child’s hospital team - you can change your mind at any time. The hospital team is not allowed to talk to anyone else about it, even family members, without your permission as parent or carer.
Older children will be involved in deciding what they want to know about their prognosis, and who to share that information with.
Our research into childhood leukaemia
Since we were founded in 1960, we have had some of our biggest research breakthroughs in the childhood leukaemia. Find out how research gives so many families hope, now and in the future.
Worried or have questions about prognosis?
We can talk you through it and support you to have conversations with your doctor.